77 related articles for article (PubMed ID: 21664731)
21. Synthesis and in vitro antimicrobial evaluation of 5-(1-methyl-5-nitro-2-imidazolyl)-4H-1,2,4-triazoles.
Shafiee A; Sayadi A; Roozbahani MH; Foroumadi A; Kamal F
Arch Pharm (Weinheim); 2002 Dec; 335(10):495-9. PubMed ID: 12506398
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.
Kim P; Kang S; Boshoff HI; Jiricek J; Collins M; Singh R; Manjunatha UH; Niyomrattanakit P; Zhang L; Goodwin M; Dick T; Keller TH; Dowd CS; Barry CE
J Med Chem; 2009 Mar; 52(5):1329-44. PubMed ID: 19209893
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 1,2,3-triazole linked galactopyranosides and evaluation of cholera toxin inhibition.
Leaver DJ; Dawson RM; White JM; Polyzos A; Hughes AB
Org Biomol Chem; 2011 Dec; 9(24):8465-74. PubMed ID: 22048800
[TBL] [Abstract][Full Text] [Related]
24. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activities of some 4,5-dihydro-1H-1,2,4-triazol-5-ones.
Yüksek H; Demirbaş A; Ikizler A; Johansson CB; Celik C; Ikizler AA
Arzneimittelforschung; 1997 Apr; 47(4):405-9. PubMed ID: 9150862
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
Wilkinson BL; Long H; Sim E; Fairbanks AJ
Bioorg Med Chem Lett; 2008 Dec; 18(23):6265-7. PubMed ID: 18926698
[TBL] [Abstract][Full Text] [Related]
28. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
[TBL] [Abstract][Full Text] [Related]
29. 1-Alkyl-2-nitroimidazol-5-yl derivatives II. N-substituted nitrones.
Cavalleri B; Ballotta R; Arioli V
Arzneimittelforschung; 1975 Mar; 25(3):338-40. PubMed ID: 239726
[No Abstract] [Full Text] [Related]
30. Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles.
Walczak K; Gondela A; Suwiński J
Eur J Med Chem; 2004 Oct; 39(10):849-53. PubMed ID: 15464618
[TBL] [Abstract][Full Text] [Related]
31. 1-Alkyl-2-nitroimidazol-5-yl derivatives. I.
Cavalleri B; Volpe G; Pallanza R
Arzneimittelforschung; 1975 Feb; 25(2):148-52. PubMed ID: 235267
[No Abstract] [Full Text] [Related]
32. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles.
Letafat B; Emami S; Aliabadi A; Mohammadhosseini N; Moshafi MH; Asadipour A; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2008 Aug; 341(8):497-501. PubMed ID: 18618489
[TBL] [Abstract][Full Text] [Related]
33. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antituberculosis action of some new pyruvic acid derivatives.
Ungureanu M; Diculencu D; Archip C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):860-4. PubMed ID: 20201282
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antifungal activity of 2-aryl-1,2,4-triazolo[1,5-a]pyridine derivatives.
Luo Y; Hu Y
Arch Pharm (Weinheim); 2006 May; 339(5):262-6. PubMed ID: 16572482
[TBL] [Abstract][Full Text] [Related]
36. Some nitroimidazole derivatives as possible antibacterial agents.
Demirayak S; Kiraz N
Farmaco; 1993 Mar; 48(3):443-6. PubMed ID: 8323675
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents.
Sangshetti JN; Nagawade RR; Shinde DB
Bioorg Med Chem Lett; 2009 Jul; 19(13):3564-7. PubMed ID: 19464891
[TBL] [Abstract][Full Text] [Related]
38. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
Zahajská L; Klimesová V; Kocí J; Waisser K; Kaustová J
Arch Pharm (Weinheim); 2004 Oct; 337(10):549-55. PubMed ID: 15476287
[TBL] [Abstract][Full Text] [Related]
40. Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach.
Banfi E; Scialino G; Zampieri D; Mamolo MG; Vio L; Ferrone M; Fermeglia M; Paneni MS; Pricl S
J Antimicrob Chemother; 2006 Jul; 58(1):76-84. PubMed ID: 16709593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
